Trial intelligence / Profile preview

Thymoglobulin PK/PD in Paediatric HSCT Recipients

NCT01135537Phase 2Terminated

Sponsor
SickKids
Start
Nov 2009
Primary completion
Jan 2014
Countries
1
01

Overview

A Phase 2 trial of antithymocyte globulin in graft-versus-host disease (GVHD), graft rejection, sponsored by SickKids. Started Nov 2009; status: terminated.

02

Drugs

antithymocyte globulin
03

Conditions

graft-versus-host disease (GVHD)graft rejection

Beyond the preview

Go deeper on NCT01135537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01135537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call